For several years now, Themis has been looking to expand its operations beyond the US and Europe. Japan was identified as the most promising market for their services due to the size and strength of the pharmaceutical companies there and their increasing moves to globalise their business. Themis participated in the UK Bio Pharma trade mission to Tokyo and Osaka in 2009 which confirmed their opinion of the opportunities there, but the company felt it was not, at that point, ready to succeed in entering the Japan market.
Now, a few years later, they have strengthened and improved their organisation and offerings and feel the time is right to focus on Japan again. They have identified a local business partner to help them in that and are currently drawing up plans for their approach, which they expect to start implementing from May of this year. Brian, who has more than 12 years previous experience working in Japan, realises it will be a challenging and possibly somewhat time consuming experience, but the company are prepared for that and believe the potential rewards for their business make it more than worth the effort.
Brian is excited to have the chance to work in Japan again, and we are looking forward to working with him over the coming months in preparation for his visit to the market.[else_memb_has_membership] [/memb_has_membership]
If your company is planning to visit Japan or even thinking about the prospect, please do get in touch with us to see how we might be able to support you in the market.
If you are looking for more in-depth information on working with Japanese pharmaceutical companies, watch our series of recorded-webinars with the likes of Takeda, Eisai and Daiichi Sankyo to understand what opportunities exist to collaborate in Japan.
Article by UKTI Japan, March 2015